echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Pharmaceutical Marketing > Provincial procurement rules have changed! Quality grouping is no longer carried out, and the purchasing power is in the hospital

    Provincial procurement rules have changed! Quality grouping is no longer carried out, and the purchasing power is in the hospital

    • Last Update: 2023-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the Jiangsu Provincial Medical Insurance Bureau issued the "Announcement on Soliciting Opinions on the Third Round of Centralized Drug Procurement Plan of the Province"
    .
    In the draft for comments, the key details such as the procurement catalogue of the third round of centralized procurement of drugs in Jiangsu Province have not yet been clarified, but the general outline
    of this centralized procurement has been shown.
     
    Previously, Jiangsu has carried out two rounds of procurement
    with volume.
    What are the innovations or differences in the rules of this round of volume procurement? What does it mean for pharmaceutical companies?
     
    Grouping rules
     
    Without quality grouping, clinical recognition is key
     
    Provincial procurement with volume is mainly for unevaluated products, so quality grouping is generally carried out, in which the original research and evaluated products will be grouped
    separately.
    However, there is no longer a quality group
    in the latest version of the draft rules for procurement with volume in Jiangsu Province.
     
    The Draft for Comments proposes to group enterprises according to the number of enterprises declared by the same variety and the procurement volume of each enterprise in the previous year's provincial platform, and the specific method is as follows:
     
     
    There is no group within 5 companies, and more than 6 companies are divided into two groups, such grouping rules can slightly ease the bidding pressure
    between enterprises.
    The variety of more than 6 declared enterprises is grouped according to the platform procurement volume, which means that the recognition rate of medical institutions has a very critical impact
    on the results of volume procurement.
     
    Winning rules
     
    The national price linkage, the quotation shall not be higher than the limit price
     
    In recent years, the provinces of the country to carry out price linkage, the country's provinces, inter-provincial alliance the lowest selection price as the quotation limit more and more, Jiangsu third round of volume procurement also refer to the national provincial or inter-provincial alliance volume procurement of the lowest selection (alternative) price (hereinafter referred to as the national lowest price), all declared product quotations shall not be higher than the national lowest price of this product and Jiangsu Province online price, higher than the invalid quotation
    .
     
     
    In addition, Jiangsu also adopts "price correction" to ensure the effect of price reduction, and the enterprises to be selected who do not accept the requirements of price correction will be disqualified and will not be replaced
    .
     
     
    Inter-group correction can effectively prevent enterprises from colluding and avoid the situation
    that the decline rate of individual varieties is not high.
    The rules of correction within the group make the price gap of the selected products in the same group only 1.
    8 times the most, avoiding the situation that the price gap between the selected price is too large, and giving a reassurance to the pharmaceutical companies selected at low prices
    .
     
    Previously, in the second round of procurement, the proposed selected enterprises that did not accept price correction were disqualified from the proposed selection, and the unselected enterprises were inquired according to the rules in order of quotation from lowest to
    highest.
    This time, enterprises will no longer be given the opportunity to
    "pick up leaks".
     
    The first two rounds of procurement in Jiangsu Province are both 1 year and will be extended
    according to the situation.
    The Draft Opinion points out that the third round of procurement in Jiangsu Province is 2 years, which can be extended by 1 year
    if necessary.
    With the longer the time, there are more variables that may occur, so companies must carefully consider
    when quoting.
     
    Non-exclusive
     
    Variety purchase volume
     
    The winning choice is the threshold
     
    Procurement authority rests with hospitals
     
    For exclusive varieties, the agreed purchase quantity shall be allocated in accordance with the winning rules, that is, if the quotation of exclusive varieties is not higher than the lowest price in the country, it is proposed to be selected
    .
    Those selected in the province with the lowest price will bring 80% of their own intention; In the lowest-priced provinces, with 30% of their own intentional volume, on this basis, for every 1% increase in the reduction rate, the proportion of the volume increases by 5%.

    This fully reflects the principle of "volume-price linkage" and increases the enthusiasm of enterprises to reduce prices independently
    .
     
    For non-exclusive varieties, the agreed purchase quantity is divided into two parts: 20% priority + 60% surplus
    .
     
     
     
    It can be seen from the rule of "20% priority + 60% surplus" that medical institutions have a certain degree of free choice, and medical institutions are not the ones who must purchase the lowest price
    .
    For enterprises, the selection of procurement with volume is only the threshold for products to enter the hospital, and cannot guarantee the purchase volume, which once again reflects the importance of medical institutions' product recognition of
    enterprises.
     
    From the perspective of the industry, the third round of centralized procurement of drugs in Jiangsu Province has incorporated new ideas
    in giving full play to the advantages of volume-based procurement and reflecting the principle of volume-price linkage.
    Under this rule, all products that remain in the Jiangsu market will be products with suitable prices, and no more ultra-high-priced varieties will remain in the market, which provides a good reference template
    for the volume procurement that other provinces will carry out in the future.
     
    What changes will be made to the Draft in the future? And which products will be included in the procurement catalog? The new media center of "Medical Economics News" will continue to pay attention
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.